Drug · DIN 02442906
RIZATRIPTAN ODT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 23, 2015; first marketed July 23, 2015.
- Drug Identification Number (DIN)
- 02442906
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Orally-Disintegrating)
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- June 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 23, 2015: NOC 17125Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named RIZATRIPTAN ODT
- DIN 02442914 · Marketed
- DIN 02446111 · Marketed
- DIN 02446138 · Marketed
- DIN 02405415 · Cancelled Pre Market
- DIN 02405423 · Cancelled Pre Market